---
title: "TuHURA Biosciences (HURA.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/HURA.US/norm.md"
symbol: "HURA.US"
name: "TuHURA Biosciences"
parent: "https://longbridge.com/zh-CN/quote/HURA.US.md"
datetime: "2026-06-10T08:46:15.194Z"
locales:
  - [en](https://longbridge.com/en/quote/HURA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HURA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HURA.US/norm.md)
---

# TuHURA Biosciences (HURA.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1256 | -0.1276 | -0.1402 | -0.2138 | -0.1536 |
| ROE | -138.43% | -145.63% | -159.34% | -265.08% | -223.21% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -7.54M | -6.76M | -7.10M | -9.53M | -6.67M |
| 营业利润 | -7.53M | -8.39M | -6.73M | -5.98M | -6.60M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 29.70M | 27.35M | 25.70M | 34.62M | 14.64M |
| 权益乘数 | 1.28 | 1.31 | 1.53 | 1.78 | 1.49 |
| 每股净资产 | 0.3604 | 0.3481 | 0.3219 | 0.3841 | 0.2193 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 6.30M | 3.62M | 2.70M | 8.51M | 6.22M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 675645.00 | 685169.00 | 378039.00 | 266682.00 | 313297.00 |
| 净债务 | -5.84M | -2.92M | -1.99M | -7.95M | -6.06M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -4.41M | -5.56M | -11.09M | -6.25M | -4.74M |
| 投资现金流 | -48846.00 | -27850.00 | 0.0000 | -156464.00 | -1.15M |
| 融资现金流 | 7.14M | 6.51M | 5.27M | 8.70M | -547878.00 |
| 自由现金流 | -1.28M | -5.99M | -7.36M | 10.35M | -4.43M |
| 现金流充裕率 | -1702.96% | -302.51% | -1916.64% | -81675.32% | -10586.05% |
| 举债与偿债 | - | 3.00M | - | - | - |
| 资本支出 | -48846.00 | -27850.00 | 0.0000 | -5561.00 | -42672.00 |